INDO US BIO-TECH | ADVANTA. | INDO US BIO-TECH/ ADVANTA. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.6 | 112.0 | 38.0% | View Chart |
P/BV | x | 8.0 | 10.7 | 74.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH ADVANTA. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-24 |
ADVANTA. Dec-14 |
INDO US BIO-TECH/ ADVANTA. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 304 | 395 | 77.0% | |
Low | Rs | 90 | 96 | 93.5% | |
Sales per share (Unadj.) | Rs | 36.3 | 179.3 | 20.3% | |
Earnings per share (Unadj.) | Rs | 4.1 | 9.9 | 41.6% | |
Cash flow per share (Unadj.) | Rs | 4.5 | 14.6 | 31.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 31.3 | 88.7 | 35.3% | |
Shares outstanding (eoy) | m | 20.05 | 84.37 | 23.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 5.4 | 1.4 | 396.1% | |
Avg P/E ratio | x | 47.9 | 24.8 | 193.1% | |
P/CF ratio (eoy) | x | 43.6 | 16.8 | 259.2% | |
Price / Book Value ratio | x | 6.3 | 2.8 | 227.4% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 3,951 | 20,715 | 19.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 9 | 2,087 | 0.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 728 | 15,126 | 4.8% | |
Other income | Rs m | 3 | 65 | 4.9% | |
Total revenues | Rs m | 732 | 15,191 | 4.8% | |
Gross profit | Rs m | 108 | 2,348 | 4.6% | |
Depreciation | Rs m | 8 | 395 | 2.0% | |
Interest | Rs m | 15 | 1,198 | 1.3% | |
Profit before tax | Rs m | 88 | 820 | 10.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 6 | -15 | -36.3% | |
Profit after tax | Rs m | 83 | 835 | 9.9% | |
Gross profit margin | % | 14.8 | 15.5 | 95.6% | |
Effective tax rate | % | 6.3 | -1.9 | -338.0% | |
Net profit margin | % | 11.3 | 5.5 | 205.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 731 | 12,692 | 5.8% | |
Current liabilities | Rs m | 175 | 9,191 | 1.9% | |
Net working cap to sales | % | 76.4 | 23.1 | 329.9% | |
Current ratio | x | 4.2 | 1.4 | 303.1% | |
Inventory Days | Days | 1 | 9 | 13.3% | |
Debtors Days | Days | 95,439,526 | 1,417 | 6,736,000.7% | |
Net fixed assets | Rs m | 107 | 7,792 | 1.4% | |
Share capital | Rs m | 201 | 169 | 118.8% | |
"Free" reserves | Rs m | 427 | 7,313 | 5.8% | |
Net worth | Rs m | 627 | 7,482 | 8.4% | |
Long term debt | Rs m | 28 | 4,638 | 0.6% | |
Total assets | Rs m | 838 | 20,484 | 4.1% | |
Interest coverage | x | 6.8 | 1.7 | 403.5% | |
Debt to equity ratio | x | 0 | 0.6 | 7.2% | |
Sales to assets ratio | x | 0.9 | 0.7 | 117.7% | |
Return on assets | % | 11.7 | 9.9 | 117.4% | |
Return on equity | % | 13.2 | 11.2 | 117.8% | |
Return on capital | % | 15.7 | 16.7 | 94.6% | |
Exports to sales | % | 0 | 2.8 | 0.0% | |
Imports to sales | % | 0 | 1.1 | 0.0% | |
Exports (fob) | Rs m | NA | 429 | 0.0% | |
Imports (cif) | Rs m | NA | 164 | 0.0% | |
Fx inflow | Rs m | 0 | 796 | 0.0% | |
Fx outflow | Rs m | 0 | 340 | 0.0% | |
Net fx | Rs m | 0 | 456 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -46 | -1,093 | 4.2% | |
From Investments | Rs m | 43 | -121 | -35.4% | |
From Financial Activity | Rs m | 12 | -23 | -52.9% | |
Net Cashflow | Rs m | 9 | -747 | -1.2% |
Indian Promoters | % | 70.2 | 61.9 | 113.5% | |
Foreign collaborators | % | 0.0 | 11.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 18.7 | - | |
FIIs | % | 0.0 | 18.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 27.2 | 109.7% | |
Shareholders | 973 | 5,290 | 18.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | ADVANTA INDIA |
---|---|---|
1-Day | -1.42% | 0.82% |
1-Month | -0.82% | 12.10% |
1-Year | 34.47% | 28.08% |
3-Year CAGR | 79.07% | 78.97% |
5-Year CAGR | 54.26% | 28.34% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the ADVANTA INDIA share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of ADVANTA INDIA the stake stands at 72.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of ADVANTA INDIA.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
ADVANTA INDIA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of ADVANTA INDIA.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.